International Journal of Advanced Culture Technology

The International Promotion Agency of Culture Technology (국제문화기술진흥원)
권호 표지
DOI QR코드

DOI QR Code

Understanding Parkinson's Disorders: Classification and Evaluation Methods, Movement Disorders, and Treatment Methods

  • Jung-Ho Lee (Dept. of physical therapy, Kyungdong Univ.)
  • Received : 2023.07.02
  • Accepted : 2023.07.31
  • Published : 2023.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Parkinson's disease is a complex neurodegenerative disease characterized by the progressive loss of dopamine-producing neurons in the substantia nigra, resulting in a variety of motor and non-motor symptoms. This study aimed to provide a comprehensive overview of Parkinson's disease, including classification of Parkinson's disease, impairment due to impairment, how disability is assessed, and how it is treated. Major symptoms of Parkinson's disease include tremors, stiffness, bradykinesia, and postural instability, and treatment methods include rehabilitation through drugs, surgical procedures, physical therapy, and occupational therapy. Early diagnosis, individualized treatment interventions, and comprehensive treatment involving a multidisciplinary medical team will be essential to manage Parkinson's disease and improve patients' quality of life. In conclusion, this study will provide comprehensive information on the complex nature of Parkinson's disease and serve as a useful guide for healthcare providers designing treatment plans for Parkinson's patients.

Keywords

References

  1. P.-L. Zhang, Y. Chen, C.-H. Zhang, Y.-X. Wang, and P. Fernandez-Funez, "Genetics of Parkinson's disease and related disorders", J. Med. Genet., Vol. 55, No. 2, pp 73-80, 2 2018. https://doi.org/10.1136/jmedgenet-2017-105047
  2. P. A. Kempster, B. Hurwitz, and A. J. Lees, "A new look at James Parkinson's Essay on the Shaking Palsy", Neurology, Vol. 69, No. 5, pp 482-485, 7 2007. https://doi.org/10.1212/01.wnl.0000266639.50620.d1
  3. R. F. Pfeiffer, "Non-motor symptoms in Parkinson's disease", Parkinsonism Relat. Disord., Vol. 22 Suppl 1, pp S119-122, 1 2016. https://doi.org/10.1016/j.parkreldis.2015.09.004
  4. M. J. Armstrong, and M. S. Okun, "Diagnosis and Treatment of Parkinson Disease: A Review", JAMA, Vol. 323, No. 6, pp 548-560, 2 2020. https://doi.org/10.1001/jama.2019.22360
  5. A. Atik, T. Stewart, and J. Zhang, "Alpha-Synuclein as a Biomarker for Parkinson's Disease", Brain Pathol. Zurich Switz., Vol. 26, No. 3, pp 410-418, 5 2016. https://doi.org/10.1111/bpa.12370
  6. M. S. Islam, et al., "Pesticides and Parkinson's disease: Current and future perspective", J. Chem. Neuroanat., Vol. 115, p 101966, 9 2021.
  7. C. Raza, R. Anjum, and N. U. A. Shakeel, "Parkinson's disease: Mechanisms, translational models and management strategies", Life Sci., Vol. 226, pp 77-90.
  8. M. Guo, et al., "Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease", Brain J. Neurol., Vol. 143, No. 5, pp 1476-1497, 5 2020. https://doi.org/10.1093/brain/awaa090
  9. S. Y. H. Lee, N. J. Yates, and S. J. Tye, "Inflammatory Mechanisms in Parkinson's Disease: From Pathogenesis to Targeted Therapies", Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry, Vol. 28, No. 5, pp 485-506, 10 2022. https://doi.org/10.1177/1073858421992265
  10. J. Opara, A. Malecki, E. Malecka, and T. Socha, "Motor assessment in Parkinson's disease", Ann. Agric. Environ. Med. AAEM, Vol. 24, No. 3, pp 411-415, 9 2017. https://doi.org/10.5604/12321966.1232774
  11. Y. J. Zhao, et al., "Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times", Mov. Disord. Off. J. Mov. Disord. Soc., Vol. 25, No. 6, pp 710-716, 4 2010. https://doi.org/10.1002/mds.22875
  12. N. Ramsay, et al., "Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease", Parkinsonism Relat. Disord., Vol. 76, pp 49-53, 7 2020. https://doi.org/10.1016/j.parkreldis.2020.05.034
  13. D. A. Bennett, K. M. Shannon, L. A. Beckett, C. G. Goetz, and R. S. Wilson, "Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale", Neurology, Vol. 49, No. 6, pp 1580-1587, 12 1997.
  14. B. R. Bloem, M. S. Okun, and C. Klein, "Parkinson's disease", Lancet Lond. Engl., Vol. 397, No. 10291, pp 2284-2303, 6 2021. https://doi.org/10.1016/S0140-6736(21)00218-X
  15. S. Sveinbjornsdottir, "The clinical symptoms of Parkinson's disease", J. Neurochem., Vol. 139 Suppl 1, pp 318-324, 10 2016. https://doi.org/10.1111/jnc.13691
  16. S. Kumar, L. Goyal, and S. Singh, "Tremor and Rigidity in Patients with Parkinson's Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors", CNS Neurol. Disord. Drug Targets, Vol. 21, No. 7, pp 596-609, 2022. https://doi.org/10.2174/1871527320666211006142100
  17. H.-Y. Chu, "Synaptic and cellular plasticity in Parkinson's disease", Acta Pharmacol. Sin., Vol. 41, No. 4, pp 447-452, 4 2020. https://doi.org/10.1038/s41401-020-0371-0
  18. D. Fredericks, J. C. Norton, C. Atchison, R. Schoenhaus, and M. W. Pill, "Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden", Am. J. Manag. Care, Vol. 23, No. 5 Suppl, pp S83-S92, 4 2017.
  19. A. Tarakad, and J. Jankovic, "Diagnosis and Management of Parkinson's Disease", Semin. Neurol., Vol. 37, No. 2, pp 118-126, 4 2017. https://doi.org/10.1055/s-0037-1601888
  20. N. A. Gouda, A. Elkamhawy, and J. Cho, "Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update", Biomedicines, Vol. 10, No. 2, p 371, 2 2022.
  21. R. Cano-de-la-Cuerda, L. Vela-Desojo, J. C. Miangolarra-Page, Y. Macias-Macias, and E. Munoz-Hellin, "Axial rigidity and quality of life in patients with Parkinson's disease: a preliminary study", Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil., Vol. 20, No, 6, pp 817-823, 8 2011. https://doi.org/10.1007/s11136-010-9818-y
  22. A. Vieira de Moraes Filho, et al., "Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson's Disease", Clin. Interv. Aging, Vol. 15, pp 87-95, 2020. https://doi.org/10.2147/CIA.S231359
  23. H. Hasan, D. S. Athauda, T. Foltynie, and A. J. Noyce, "Technologies Assessing Limb Bradykinesia in Parkinson's Disease", J. Park. Dis., Vol. 7, No. 1, pp 65-77, 2017. https://doi.org/10.3233/JPD-160878
  24. S. Y. Kang, et al., "Characteristics of the sequence effect in Parkinson's disease", Mov. Disord., Vol. 25, No. 13, pp 2148-2155, 2010. https://doi.org/10.1002/mds.23251
  25. P. Zham, et al., "A Kinematic Study of Progressive Micrographia in Parkinson's Disease", Front. Neurol., Vol. 10, p 403, 4 2019.
  26. M. T. Hayes, "Parkinson's Disease and Parkinsonism", Am. J. Med., Vol. 132, No. 7, pp 802-807, 7 2019. https://doi.org/10.1016/j.amjmed.2019.03.001
  27. J. J. Crouse, J. R. Phillips, M. Jahanshahi, and A. A. Moustafa, "Postural instability and falls in Parkinson's disease:", Rev. Neurosci., Vol. 27, No. 5, pp 549-555, 7 2016. https://doi.org/10.1515/revneuro-2016-0002
  28. H. Kataoka, et al., "Can Postural Instability Respond to Galvanic Vestibular Stimulation in Patients with Parkinson's Disease?", J. Mov. Disord., Vol. 9, No. 1, pp 40-43, 1 2016. https://doi.org/10.14802/jmd.15030
  29. S. Rinalduzzi, et al., "Balance Dysfunction in Parkinson's Disease", BioMed Res. Int., Vol. 2015, p e434683, 1 2015.
  30. A. Mirelman, et al., "Gait impairments in Parkinson's disease", Lancet Neurol., Vol. 18, No. 7, pp 697-708, 7 2019. https://doi.org/10.1016/S1474-4422(19)30044-4
  31. I. Mazzetta, A. Zampogna, A. Suppa, A. Gumiero, M. Pessione, and F. Irrera, "Wearable Sensors System for an Improved Analysis of Freezing of Gait in Parkinson's Disease Using Electromyography and Inertial Signals", Sensors, Vol. 19, No. 4, p 948, 1 2019.
  32. A. H. Snijders, et al., "Physiology of freezing of gait", Ann. Neurol., Vol. 80, No. 5, pp 644-659, 2016. https://doi.org/10.1002/ana.24778
  33. J. Nonnekes, A. H. Snijders, J. G. Nutt, G. Deuschl, N. Giladi, and B. R. Bloem, "Freezing of gait: a practical approach to management", Lancet Neurol., Vol. 14, No. 7, pp 768-778, 7 2015. https://doi.org/10.1016/S1474-4422(15)00041-1
  34. A. Mirelman, et al., "Arm swing as a potential new prodromal marker of Parkinson's disease", Mov. Disord., Vol. 31, No. 10, pp 1527-1534, 2016. https://doi.org/10.1002/mds.26720
  35. G. Abbruzzese, R. Marchese, L. Avanzino, and E. Pelosin, "Rehabilitation for Parkinson's disease: Current outlook and future challenges", Parkinsonism Relat. Disord., Vol. 22, pp S60-S64, 1 2016.
  36. J. Zhang, and L. Chew-Seng Tan, "Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist", Curr. Neuropharmacol., Vol. 14, No. 4, pp 356-363, 5 2016. https://doi.org/10.2174/1570159X14666151208114634
  37. M. Senek, E. I. Nielsen, and D. Nyholm, "Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study", Mov. Disord., Vol. 32, No. 2, pp 283-286, 2017. https://doi.org/10.1002/mds.26855
  38. J. Perez-Perez, et al., "Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients", Drugs Aging, Vol. 32, No. 5, pp 401-407, 5 2015. https://doi.org/10.1007/s40266-015-0264-y
  39. E. Jaakkola, J. Joutsa, E. Makinen, J. Johansson, and V. Kaasinen, "Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease", Eur. J. Neurol., Vol. 24, No. 11, pp 1341-1347, 2017. https://doi.org/10.1111/ene.13390
  40. N. Malek, "Deep Brain Stimulation in Parkinson's Disease", Neurol. India, Vol. 67, No. 4, pp 968-978, 2019. https://doi.org/10.4103/0028-3886.266268
  41. J. G. V. Habets, M. Heijmans, M. L. Kuijf, M. L. F. Janssen, Y. Temel, and P. L. Kubben, "An update on adaptive deep brain stimulation in Parkinson's disease", Mov. Disord., Vol. 33, No. 12, pp 1834-1843, 2018. https://doi.org/10.1002/mds.115
  42. M. K. Mak, I. S. Wong-Yu, X. Shen, and C. L. Chung, "Long-term effects of exercise and physical therapy in people with Parkinson disease", Nat. Rev. Neurol., Vol. 13, No 11, Art. No. 11, 11 2017.
  43. D. L. M. Radder, I. H. Sturkenboom, M. van Nimwegen, S. H. Keus, B. R. Bloem, and N. M. de Vries, "Physical therapy and occupational therapy in Parkinson's disease", Int. J. Neurosci., Vol. 127, No. 10, pp 930-943, 10 2017. https://doi.org/10.1080/00207454.2016.1275617
  44. P. Alves Da Rocha, J. McClelland, and M. E. Morris, "Complementary physical therapies for movement disorders in Parkinson's disease: a systematic review", Eur. J. Phys. Rehabil. Med., Vol. 51, No. 6, pp 693-704, 12 2015.
  45. K. Gordt, T. Gerhardy, B. Najafi, and M. Schwenk, "Effects of Wearable Sensor-Based Balance and Gait Training on Balance, Gait, and Functional Performance in Healthy and Patient Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials", Gerontology, Vol. 64, No. 1, pp 74-89, 2018. https://doi.org/10.1159/000481454
  46. C. L. H. Chung, S. Thilarajah, and D. Tan, "Effectiveness of resistance training on muscle strength and physical function in people with Parkinson's disease: a systematic review and meta-analysis", Clin. Rehabil., Vol. 30, No. 1, pp 11-23, 1 2016. https://doi.org/10.1177/0269215515570381
  47. J. Y. Y. Kwok, et al., "Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People with Parkinson Disease: A Randomized Clinical Trial", JAMA Neurol., Vol. 76, No. 7, pp 755-763, 7 2019. https://doi.org/10.1001/jamaneurol.2019.0534
  48. J. F. Baizabal-Carvallo, M. Alonso-Juarez, and R. Fekete, "Anti-Gravity Treadmill Training for Freezing of Gait in Parkinson's Disease", Brain Sci., Vol. 10, No 10, Art. No. 10, 10 2020.
  49. D. G. Rutz, and D. H. Benninger, "Physical Therapy for Freezing of Gait and Gait Impairments in Parkinson Disease: A Systematic Review", PM&R, Vol. 12, No. 11, pp 1140-1156, 2020. https://doi.org/10.1002/pmrj.12337
  50. G. Bonassi, E. Pelosin, C. Ogliastro, C. Cerulli, G. Abbruzzese, and L. Avanzino, "Mirror Visual Feedback to Improve Bradykinesia in Parkinson's Disease", Neural Plast., Vol. 2016, p e8764238, 8 2016.
  51. C. Chattoraj, A. Kumar, A. Munda, and S. Das, "Robotic Assistance in Locomotive Health Recovery: A review", J. Energy Eng. Thermodyn, Vol. 3, No. 1, pp 10-19, 2023. https://doi.org/10.55529/jeet.31.10.19
  52. E. R. Foster, L. G. Carson, J. Archer, and E. G. Hunter, "Occupational Therapy Interventions for Instrumental Activities of Daily Living for Adults with Parkinson's Disease: A Systematic Review", Am. J. Occup. Ther., Vol. 75, No. 3, p 7503190030, 4 2021.
  53. E. R. Foster, D. Spence, and J. Toglia, "Feasibility of a cognitive strategy training intervention for people with Parkinson's disease", Disabil. Rehabil., Vol. 40, No. 10, pp 1127-1134, 5 2018. https://doi.org/10.1080/09638288.2017.1288275